7 hours ago
1
Sundry Photography
Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on the drugmaker’s guidance amid U.S. President Donald Trump’s ongoing threats to impose tariffs on the sector.
The New Brunswick, New Jersey-based
English (US) ·